4.7 Review

Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy

Related references

Note: Only part of the references are listed.
Article Physiology

Sarcomere length affects Ca2+ sensitivity of contraction in ischemic but not non-ischemic myocardium

Bertrand C. W. Tanner et al.

Summary: Isometric force-pCa relationships were measured in human myocardial strips at physiological temperature. Ca2+ sensitivity increased with sarcomere length in samples from donors and patients with ischemic heart failure, but not in samples from patients with non-ischemic heart failure. Troponin I and cMyBP-C phosphorylation promote length-dependent activation, which is blunted in myocardium from patients with ischemic heart failure and further reduced in myocardium from patients with non-ischemic heart failure.

JOURNAL OF GENERAL PHYSIOLOGY (2023)

Article Biochemistry & Molecular Biology

Cirrhotic Cardiomyopathy Following Bile Duct Ligation in Rats-A Matter of Time?

Moritz Uhlig et al.

Summary: Cirrhotic patients often experience cirrhotic cardiomyopathy (CCM), which is studied in detail through animal models of bile duct ligation (BDL) and a second surgery. The study reveals delayed adaptability, impaired contractility at rest, reduced contractile reserve, increased creatine and transaminase levels, myocardial fibrosis, macrophage infiltration, systemic inflammation, altered expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1a), and increased expression of caspase-3. Structural changes in the myocardium are observed after 8 weeks. Transient myocardial insufficiency and secondary organ dysfunction occur after the second surgery.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Gastroenterology & Hepatology

Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension

Bert Vandenberk et al.

Summary: This article provides a comprehensive overview of the diagnosis, pathophysiology, and management of atrial fibrillation (AF) in patients with cirrhosis. It highlights the increased prevalence of AF in cirrhosis patients and the associated adverse outcomes, emphasizing the need for careful consideration of treatment options.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Elevated bile acids are associated with left ventricular structural changes in biliary atresia

Manpreet K. Virk et al.

Summary: In children with biliary atresia, elevated serum bile acid levels are associated with abnormal left ventricular geometry, suggesting that bile acid excess may be a potential trigger for myocardial structural changes.

HEPATOLOGY COMMUNICATIONS (2023)

Review Medicine, Research & Experimental

Targeting ryanodine receptors to treat human diseases

Andrew R. Marks

Summary: This Review provides an update on the role of ryanodine receptors (RyRs) in human diseases of heart, muscle, and brain. Intracellular Ca2+ overload caused by RyR malfunction can lead to loss of function and death. RyRs are present throughout the animal kingdom and have been found to play a role in the pathogenesis of various disorders. Therapeutic interventions targeting dysfunctional RyRs show promise in treating these diseases.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Physiology

Adrenergic Regulation of Calcium Channels in the Heart

Arianne Papa et al.

Summary: This article describes the mechanisms of calcium influx and contractility in the heart during cardiac contraction. Research has found that agonists of the sympathetic nervous system activate calcium influx in cardiomyocytes through cascading signal transduction pathways and PKA, resulting in increased contractility of the heart muscle cells.

ANNUAL REVIEW OF PHYSIOLOGY (2022)

Article Gastroenterology & Hepatology

Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study

Achintya D. Singh et al.

Summary: This study found that replacing the World Congress of Gastroenterology criteria with the Cirrhotic Cardiomyopathy Consortium criteria did not significantly affect the diagnosis frequency and clinical outcomes. Patients with advanced diastolic dysfunction according to the Consortium criteria were more likely to experience pre-transplant mortality and complications of acute kidney injury/hepatic encephalopathy. These patients may benefit from further monitoring and treatment.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes

Ashle Spann et al.

Summary: Cardiovascular disease is a significant concern after liver transplantation, and cirrhotic cardiomyopathy is a risk factor for this. This study compares two sets of criteria for cirrhotic cardiomyopathy and finds that the revised criteria are more predictive of major adverse cardiac events. The study also identifies a specific echocardiographic variable, low septal e', as highly predictive of these events after transplantation.

LIVER TRANSPLANTATION (2022)

Review Cardiac & Cardiovascular Systems

Cardiovascular events after liver transplantation: MACE hurts

Mario H. Altieri et al.

Summary: This review discusses the factors that contribute to the development of major adverse cardiovascular events (MACE) after liver transplantation and explores methods for predicting these events in the post-transplant period. It reviews the roles of metabolic syndrome, renal dysfunction, non-alcoholic fatty liver disease, diagnostic tests such as imaging and biomarkers, as well as parameters such as systolic and diastolic dysfunction, and QT interval prolongation in cardiovascular events. The review also summarizes the current literature on scoring systems for predicting cardiovascular events.

REVIEWS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy

Lixia Ma et al.

Summary: This study found that anti-beta 1-AR levels were significantly higher in CCM patients and correlated with NT-proBNP and cardiac function indicators, suggesting potential for predictive and therapeutic implications in CCM.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2022)

Review Gastroenterology & Hepatology

Prolonged QT Interval in Cirrhosis: Twisting Time?

William Lee et al.

Summary: Approximately 30% to 70% of patients with cirrhosis experience prolongation of the QT interval, which may be associated with the severity of liver disease and increased mortality. External risk factors include medication, bradycardia, and electrolyte abnormalities. Risk can be reduced through electrocardiogram monitoring and avoidance of drug interactions and electrolyte disturbances.

GUT AND LIVER (2022)

Article Biology

Prolonged β-adrenergic stimulation disperses ryanodine receptor clusters in cardiomyocytes and has implications for heart failure

Xin Shen et al.

Summary: This study investigates the promotion of RyR cluster dispersion by prolonged beta-adrenergic stimulation in heart failure, and examines the underlying mechanisms. The findings demonstrate the intimate connection between RyR localization and function through channel phosphorylation by CaMKII and PKA, which plays a protective role in healthy cardiomyocytes but contributes to impaired cardiac function during heart failure.

ELIFE (2022)

Review Biochemistry & Molecular Biology

Skeletal and cardiac muscle calcium transport regulation in health and disease

Mark A. Valentim et al.

Summary: This article discusses the release and transport of calcium ions in healthy muscle, and the impact of changes in calcium ion concentrations on signaling pathways. It also explores the relationship between calcium ion transport impairments and the pathogenesis of skeletal muscle myopathies and cardiomyopathies.

BIOSCIENCE REPORTS (2022)

Article Gastroenterology & Hepatology

The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria

Marcel Razpotnik et al.

Summary: The prevalence of cirrhotic cardiomyopathy varies significantly depending on the diagnostic criteria used, with a notably higher rate observed under the 2019 CCC criteria. More patients met the criteria for diastolic dysfunction according to the 2005 Montreal guidelines, while systolic dysfunction was more frequently diagnosed under the 2019 CCC criteria. Further long-term studies are required to validate the predictive validity of these criteria for clinically relevant outcomes.

LIVER INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

β-blockers in advanced cirrhosis: More friend than enemy

Ki Tae Yoon et al.

Summary: NSBB therapy in cirrhotic patients is effective in preventing bleeding, but may have detrimental effects in decompensated cirrhosis. While some studies suggest harmful effects of NSBBs, overall, using beta-blockers in cirrhosis seems to outweigh the risks and provide more benefits.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria

Manhal Izzy et al.

Summary: This study evaluated the prevalence of CCM according to the new criteria and its impact on posttransplant CVD, showing that CCM predicts an increased risk for new CVD following LT. Changes in CCM individual parameters pretransplant were associated with an increased risk for posttransplant CVD, highlighting the importance of addressing and mitigating these risks.

LIVER TRANSPLANTATION (2021)

Article Medicine, Research & Experimental

Myocardial Dysfunction in Cirrhotic Cardiomyopathy is Associated with Alterations of Phospholamban Phosphorylation and IL-6 Levels

Cristina Schmitt Gregolin et al.

Summary: The study demonstrates that cirrhotic cardiomyopathy is associated with decreased cardiac contractility, with alterations in phospholamban phosphorylation and higher levels of cardiac pro-inflammatory cytokine IL-6. These findings provide insights into the molecular and functional effects of liver cirrhosis on cardiac function.

ARCHIVES OF MEDICAL RESEARCH (2021)

Review Gastroenterology & Hepatology

Advances in cirrhotic cardiomyopathy

Hongqun Liu et al.

Summary: Cirrhotic cardiomyopathy (CCM) is a recognized condition that can lead to cardiac dysfunction and increased morbidity and mortality, especially during liver transplantation. Recent research has highlighted the mechanisms of CCM, such as cardiomyocyte apoptosis, inflammation, and oxidative stress, as well as potential therapeutic strategies. However, there is still a need for further research in order to develop appropriate management strategies for CCM.

CURRENT OPINION IN GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

Maurizio Cesari et al.

Summary: According to the new criteria, the prevalence of cirrhotic cardiomyopathy (CCM) is 29%, mainly due to altered global longitudinal strain (GLS) at rest. However, CCM does not have prognostic relevance for the clinical management of cirrhotic patients.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Redefining Cirrhotic Cardiomyopathy for the Modern Era

Manhal Izzy et al.

HEPATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Effect of carvedilol on atrial excitation-contraction coupling, Ca2+ release, and arrhythmogenicity

E. Martinez-Hernandez et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis

Yousef H. Darrat et al.

WORLD JOURNAL OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Treating oxidative stress in heart failure: past, present and future

Atze van der Pol et al.

EUROPEAN JOURNAL OF HEART FAILURE (2019)

Article Medicine, Research & Experimental

Internal dysregulation of the renin system in patients with stable liver cirrhosis

Annette Dam Fialla et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)

Review Cardiac & Cardiovascular Systems

Calcium Signaling Series

David A. Eisner et al.

CIRCULATION RESEARCH (2017)

Article Pharmacology & Pharmacy

Role of tumour necrosis factor-a in the regulation of T-type calcium channel current in HL-1 cells

Fang Rao et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)

Article Gastroenterology & Hepatology

Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis

Moreshwar S. Desai et al.

LIVER INTERNATIONAL (2015)

Article Medicine, Research & Experimental

Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice

Soon Woo Nam et al.

CLINICAL SCIENCE (2014)

Article Gastroenterology & Hepatology

Protective effects of erythropoietin on cirrhotic cardiomyopathy in rats

Li Liu et al.

DIGESTIVE AND LIVER DISEASE (2012)

Article Biochemistry & Molecular Biology

A theory on auto-oscillation and contraction in striated muscle

Katsuhiko Sato et al.

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure

Mamoru Mochizuki et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Defective cardiac ryanodine receptor regulation during atrial fibrillation

JA Vest et al.

CIRCULATION (2005)

Article Gastroenterology & Hepatology

Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy

CA Ward et al.

GASTROENTEROLOGY (2001)